Nuwellis Receives FDA Clearance for an Additional Dual Lumen Extended Length Peripheral Catheter

January 4, 2024

https://www.globenewswire.com/news-release/2024/01/04/2804291/26106/en/Nuwellis-Receives-FDA-Clearance-for-an-Additional-Dual-Lumen-Extended-Length-Peripheral-Catheter.html

MINNEAPOLIS, Jan. 04, 2024 (GLOBE NEWSWIRE) — Nuwellis, Inc. (Nasdaq:NUWE), a medical technology company focused on transforming the lives of people with fluid overload, today announced it has received U.S. Food and Drug Administration (FDA) clearance for its specialty peripheral dual lumen extended length catheter (dELC). The addition of a new 12 cm catheter provides clinicians who treat patients with fluid overload with an additional venous access option to use the company’s Aquadex® ultrafiltration system.

Read more at globenewswire.com

Related news for (NUWE)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.